These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6312217)

  • 21. [Herpes genitalis].
    Tannus M
    AMB Rev Assoc Med Bras; 1985; 31(9-10):152-6. PubMed ID: 3010392
    [No Abstract]   [Full Text] [Related]  

  • 22. The development of synthetic vaccines.
    Lerner RA; Green N; Olson A; Shinnick T; Sutcliffe JG
    Hosp Pract (Off Ed); 1981 Dec; 16(12):55-62. PubMed ID: 6171500
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
    Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
    Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine].
    Shiraki K; Takahara T
    Nihon Rinsho; 1993 Jan; 51(1):241-7. PubMed ID: 8381884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
    Berman PW; Gregory T; Crase D; Lasky LA
    Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus genes and their expression in E. coli.
    Pasek M; Goto T; Gilbert W; Zink B; Schaller H; MacKay P; Leadbetter G; Murray K
    Nature; 1979 Dec; 282(5739):575-9. PubMed ID: 399329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concept review of genital herpes vaccines.
    Allen WP; Rapp F
    J Infect Dis; 1982 Mar; 145(3):413-21. PubMed ID: 6278029
    [No Abstract]   [Full Text] [Related]  

  • 28. Herpes simplex virus in pregnancy: new concepts in prevention and management.
    Hill J; Roberts S
    Clin Perinatol; 2005 Sep; 32(3):657-70. PubMed ID: 16085025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
    Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
    Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural relationships between minor and major proteins of hepatitis B surface antigen.
    Stibbe W; Gerlich WH
    J Virol; 1983 May; 46(2):626-8. PubMed ID: 6842680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic engineering and properties of novel herpes simplex viruses for use as potential vaccines and as vectors of foreign genes.
    Meignier B; Roizman B
    Adv Exp Med Biol; 1989; 257():187-92. PubMed ID: 2559609
    [No Abstract]   [Full Text] [Related]  

  • 32. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
    Itoh Y; Takai E; Ohnuma H; Kitajima K; Tsuda F; Machida A; Mishiro S; Nakamura T; Miyakawa Y; Mayumi M
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9174-8. PubMed ID: 3466181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes simplex virus type-1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli.
    Watson RJ; Weis JH; Salstrom JS; Enquist LW
    Science; 1982 Oct; 218(4570):381-4. PubMed ID: 6289440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New opportunities for development of safe, effective live virus vaccines.
    Chanock RM
    Yale J Biol Med; 1982; 55(3-4):361-7. PubMed ID: 6295011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
    Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
    Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seventeen years of application of herpes vaccines in Bulgaria.
    Dundarov S; Andonov P
    Acta Virol; 1994 Aug; 38(4):205-8. PubMed ID: 7879710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. l. Hepatitis B virus].
    Sugahara K
    Nihon Rinsho; 1987 Oct; 45(10):2292-7. PubMed ID: 3448268
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
    Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
    J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
    Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
    Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.